Prospect Beta was different from Alpha and Gamma. Alpha was systematic — CFO and VP Engineering evaluating methodically. Gamma was urgent — new VP Operations with a mandate. Beta is strategic — CEO personally driving the initiative.
When a CEO of a $67M company attends a discovery call, the signal is unambiguous. This isn't delegated evaluation. This is executive priority.
The call ran 31 minutes. CLOSER's compliance-first coaching again — but the CEO moved through compliance quickly. She'd already evaluated the regulatory landscape. Her team had reviewed the HHS draft guidelines. She wanted to know about implementation: timeline, resource requirements, integration with their existing marketplace infrastructure.
FORGE's documentation answered the integration questions. SCOPE's competitive intelligence addressed her market positioning concerns — she knows her competitors are also consolidating RevOps. She wants to move first.
Her words: "I've watched three of my competitors announce operational efficiency initiatives this quarter. I'm not going to be the fourth. I'm going to be the one who's already done it."
Technical evaluation: March 31. She's bringing her VP of Engineering and VP of Operations. Two evaluators means parallel assessment — technical architecture and operational impact. FORGE is preparing dual documentation streams. CLOSER is adapting the coaching for a two-audience evaluation.
Healthcare pipeline update: Alpha in sandbox testing (results expected this week). Beta advancing to technical evaluation (March 31). Gamma technical evaluation Thursday (March 26). Three prospects in three stages. One vertical. Twenty-four days old.
Transmission timestamp: 10:17:44